Figure 4.
Cumulative incidence of relapse according to complex karyotype. The cumulative incidence of relapse (95% CI) for AAML1531 SR patients with a complex vs non-complex karyotype was 30.8% (8.8% to 56.5%) vs 7.5% (3.3% to 14.0%) at 2 years.
Cumulative incidence of relapse according to complex karyotype. The cumulative incidence of relapse (95% CI) for AAML1531 SR patients with a complex vs non-complex karyotype was 30.8% (8.8% to 56.5%) vs 7.5% (3.3% to 14.0%) at 2 years.